🎉 M&A multiples are live!
Check it out!

Actinogen Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Actinogen Medical and similar public comparables like Benevolent AI, Julphar, and Galapagos.

Actinogen Medical Overview

About Actinogen Medical

Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.


Founded

1999

HQ

Australia
Employees

n/a

Financials

LTM Revenue $5.2M

LTM EBITDA -$7.8M

EV

$45.2M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Actinogen Medical Financials

Actinogen Medical has a last 12-month revenue of $5.2M and a last 12-month EBITDA of -$7.8M.

In the most recent fiscal year, Actinogen Medical achieved revenue of n/a and an EBITDA of -$8.0M.

Actinogen Medical expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Actinogen Medical valuation multiples based on analyst estimates

Actinogen Medical P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a n/a XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$6.5M -$8.0M XXX XXX XXX
EBITDA Margin NaN% NaN% XXX XXX XXX
Net Profit -$6.0M -$6.8M XXX XXX XXX
Net Margin NaN% NaN% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Actinogen Medical Stock Performance

As of March 14, 2025, Actinogen Medical's stock price is AUD 0 (or $0).

Actinogen Medical has current market cap of AUD 94.0M (or $59.4M), and EV of AUD 71.4M (or $45.2M).

See Actinogen Medical trading valuation data

Actinogen Medical Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$45.2M $59.4M XXX XXX XXX XXX $-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Actinogen Medical Valuation Multiples

As of March 14, 2025, Actinogen Medical has market cap of $59.4M and EV of $45.2M.

Actinogen Medical's trades at 8.6x LTM EV/Revenue multiple, and -5.8x LTM EBITDA.

Analysts estimate Actinogen Medical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Actinogen Medical and 10K+ public comps

Actinogen Medical Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $45.2M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA -5.8x XXX XXX XXX
P/E -7.6x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -5.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Actinogen Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Actinogen Medical Valuation Multiples

Actinogen Medical's NTM/LTM revenue growth is 25%

Actinogen Medical's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Actinogen Medical's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Actinogen Medical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Actinogen Medical and other 10K+ public comps

Actinogen Medical Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 22% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Actinogen Medical Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Actinogen Medical M&A and Investment Activity

Actinogen Medical acquired  XXX companies to date.

Last acquisition by Actinogen Medical was  XXXXXXXX, XXXXX XXXXX XXXXXX . Actinogen Medical acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Actinogen Medical

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Actinogen Medical

When was Actinogen Medical founded? Actinogen Medical was founded in 1999.
Where is Actinogen Medical headquartered? Actinogen Medical is headquartered in Australia.
Is Actinogen Medical publicy listed? Yes, Actinogen Medical is a public company listed on ASX.
What is the stock symbol of Actinogen Medical? Actinogen Medical trades under ACW ticker.
When did Actinogen Medical go public? Actinogen Medical went public in 2007.
Who are competitors of Actinogen Medical? Similar companies to Actinogen Medical include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Actinogen Medical? Actinogen Medical's current market cap is $59.4M
What is the current revenue of Actinogen Medical? Actinogen Medical's last 12-month revenue is $5.2M.
What is the current EBITDA of Actinogen Medical? Actinogen Medical's last 12-month EBITDA is -$7.8M.
What is the current EV/Revenue multiple of Actinogen Medical? Current revenue multiple of Actinogen Medical is 8.6x.
What is the current EV/EBITDA multiple of Actinogen Medical? Current EBITDA multiple of Actinogen Medical is -5.8x.
Is Actinogen Medical profitable? Yes, Actinogen Medical is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.